Utility of Restrata With Split-thickness Skin Graft to Reconstruct the Forearm Donor Site
Phase 2
Terminated
- Conditions
- Head and Neck Cancer
- Interventions
- Device: Restrata GraftProcedure: Standard of Care Skin Graft
- Registration Number
- NCT04880603
- Lead Sponsor
- Nebraska Methodist Health System
- Brief Summary
Adult patients undergoing a radial forearm free flap or ulnar forearm free flap will be randomized to the use of the Restrata graft in combination with split-thickness skin graft for reconstruction. Photos will document whether the Restata graft aids in the healing.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 5
Inclusion Criteria
- All patients age 19 or greater that will undergo radial forearm free flap or ulnar free flap.
- Photo documentation of wound bed at two weeks and four weeks must be obtainable either by physician or patient.
Exclusion Criteria
- Active systemic immunosuppression (active use of high-dose steroids (≥40mg prednisone daily or equivalent) or other immunosuppressive medications OR medical conditions causing immunosuppression, i.e. human immunodeficiency virus etc).
- Diabetes mellitus with most recent Hemoglobin A1c ≥10.0 within 30 days prior to surgery.
- Morbid obesity (BMI >40).
- Inability to maintain wrist immobilization for full planned period.
- Severe malnutrition (prealbumin levels <10 mg per dL within 30 days prior to surgery OR BMI <15 (very severely underweight).
- Other conditions felt to significantly impair wound healing per surgeon discretion
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description B - Restrata Graft Restrata Graft - A - Standard of Care Standard of Care Skin Graft -
- Primary Outcome Measures
Name Time Method Tendon exposure 4 weeks post-operation Tendon exposure at four weeks post-operatively (Yes/No).
Percentage of surface area 4 weeks post operation Percentage of surface area of split-thickness skin graft incorporation at four weeks postoperatively.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Nebraska Methodist Hospital
🇺🇸Omaha, Nebraska, United States